Document is current

Article History

Received: 28 January 2025

Accepted: 16 June 2025

First Online: 15 July 2025

Declarations

:

: Ethical approval for the P-PUP study was obtained from the Monash University Human Research Ethics Committee (HUMREC) (ID: 26938). Additionally, each study within the research project received ethical approval from the relevant Human Research Ethics Committee.

: Not applicable.

: AEJ serves as a Board member for Androgen Excess and Polycystic Ovary Syndrome, received honoraria for presentations at educational events at Novo Nordisk, Boehringer and Merck, and is an employee of Monash Health. CTT serves as Chair of CRE-WHiRL ECR Group 2020-2023 and AEPCOS EC-SIG group 2020-2022, as a committee member of the Endocrine Society of Australia’s ECR Group. AG serves on the Editorial Board for the European Journal of Endocrinology and on the Advisory Board of the Italian Society of Endocrinology. RA serves as a consultant to May Health, Core Access Surgical Technologies, Spruce Biosciences, and Postera; is an investor in Martin Imaging; received honoraria for speaking from the Davidson-Mestman course, Merck and Stya Paul Oration; and serves on the Editorial Board for the Journal of Clinical Endocrinology and Metabolism, on the Board of Trustees for the Endocrine Society, as a member of the DSMB for grant NCT03625531; ChiCTR180001730 to The First Affiliated of Guangzhou Medical University and grant for the SUPER study to the University of Michigan, and previously served as CEO of the American Society for Reproductive Medicine. All the other authors declare that they have no conflicts of interest.